- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Adam
Harper
Associate
Adam Harper is an associate in King & Spalding’s Government Matters practice group and a member of the International Trade team in the firm’s Washington, D.C. office. Adam’s practice covers several aspects of international trade law, including economic sanctions, export controls, national security reviews of foreign investments, customs, and trade remedy proceedings in the United States.
Adam handles issues before various governmental bodies, including the Treasury Department’s Office of Foreign Assets Control, the Department of Commerce, the Committee on Foreign Investment in the United States, Customs and Border Protection, and the U.S. International Trade Commission.
Prior to joining King & Spalding, Adam worked at a prominent Washington, D.C. law firm where he handled many of the same issues. During law school, Adam performed internships with the Department of Justice, the Department of Commerce, and the United States Trade Representative.
Credentials
J.D., George Washington University Law School, cum laude
District of Columbia
Insights
Client Alert
April 9, 2021
FATF Releases Proposed Updates to Cryptocurrency Regulation Guidance
Client Alert
April 7, 2021
FinCEN Seeks Comments on CTA Beneficial Ownership Regulations
Client Alert
December 22, 2020
New BSA/AML Regime Promises Sweeping Changes
Insights
Client Alert
April 9, 2021
FATF Releases Proposed Updates to Cryptocurrency Regulation Guidance
Client Alert
April 7, 2021
FinCEN Seeks Comments on CTA Beneficial Ownership Regulations
Client Alert
December 22, 2020
New BSA/AML Regime Promises Sweeping Changes
Credentials
J.D., George Washington University Law School, cum laude
District of Columbia